Skip to content
2000
Volume 26, Issue 3
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Aim and Objective: Nanotechnology attempts to solve the problem of antibiotic resistance. Zinc oxide nanoparticles and curcumin have been shown to be antimicrobial agents and promising anticancer agents, both on their own as well as in combination, and this incorporation will likely improve these properties via a possible additive effect. Materials and Methods: In this study, the synthesis of zinc oxide nanoparticles was done by the distilled extract of Stachys byzantina via the co-precipitation method, which is an economical and eco-friendly green synthesis method. Then, curcumin was loaded to zinc oxide nanoparticles. Antibacterial efficacy of the synthesized nanoparticles was evaluated against five intracellular bacteria; moreover, cytotoxicity was evaluated on breast cancer cells. Results: To confirm the synthesis and characterization of the nanoparticles, some techniques, such as XRD, FTIR, FESEM, and EDX were used. In addition, the antimicrobial activity of biosynthetic zinc oxide/curcumin nanocomposites was evaluated against selected bacterial strains. The uniform spherical nature of the zinc oxide nanoparticles was observed in the FESEM images, with the particle sizes ranging from 20 to 40 nm. The EDX spectrum showed the presence of C, O, and Zn and curcumin uptake on zinc oxide nanoparticles. Conclusion: The zinc oxide/curcumin nanocomposites demonstrated an effective antibacterial effect in the disk diffusion method against five bacterial species. Furthermore, the zinc oxide/ curcumin nanocomposites showed a significant inhibitory effect on the growth of breast cancer cells in the MTT test. Thus, it seems that the synthesized zinc oxide/curcumin nanocomposites have promising high potential antimicrobial and cytotoxic effects.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/1386207325666220408093646
2023-03-01
2024-12-27
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/1386207325666220408093646
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test